Zhang Z - Search Results

1

Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies.

Eijkelkamp WB, Zhang Z, Brenner BM, Cooper ME, Devereux RB, Dahlöf B, Ibsen H, Keane WF, Lindholm LH, Olsen MH, Parving HH, Remuzzi G, Shahinfar S, Snapinn SM, Wachtell K, de Zeeuw D. Eijkelkamp WB, et al. Among authors: zhang z. J Hypertens. 2007 Apr;25(4):871-6. doi: 10.1097/HJH.0b013e328014953c. J Hypertens. 2007. PMID: 17351381

2

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. de Zeeuw D, et al. Among authors: zhang z. Kidney Int. 2004 Jun;65(6):2309-20. doi: 10.1111/j.1523-1755.2004.00653.x. Kidney Int. 2004. PMID: 15149345 Free article. Clinical Trial.

3

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.

de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. de Zeeuw D, et al. Among authors: zhang z. Circulation. 2004 Aug 24;110(8):921-7. doi: 10.1161/01.CIR.0000139860.33974.28. Epub 2004 Aug 9. Circulation. 2004. PMID: 15302780 Clinical Trial.

4

Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.

Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D. Eijkelkamp WB, et al. Among authors: zhang z. J Am Soc Nephrol. 2007 May;18(5):1540-6. doi: 10.1681/ASN.2006050445. Epub 2007 Apr 4. J Am Soc Nephrol. 2007. PMID: 17409317 Clinical Trial.

5

A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension.

Soffer B, Zhang Z, Miller K, Vogt BA, Shahinfar S. Soffer B, et al. Among authors: zhang z. Am J Hypertens. 2003 Oct;16(10):795-800. doi: 10.1016/s0895-7061(03)00900-2. Am J Hypertens. 2003. PMID: 14553956 Clinical Trial.

6

Detecting and managing patients with type 2 diabetic kidney disease: proteinuria and cardiovascular disease.

Mitch WE, Shahinfar S, Dickson TZ, de Zeeuw D, Zhang Z. Mitch WE, et al. Among authors: zhang z. Kidney Int Suppl. 2004 Nov;(92):S97-8. doi: 10.1111/j.1523-1755.2004.09222.x. Kidney Int Suppl. 2004. PMID: 15485428 Free article. Review.

7

Baseline predictors of end-stage renal disease risk in patients with type 2 diabetes and nephropathy: new lessons from the RENAAL Study.

Shahinfar S, Dickson T, Zhang Z, Keane WF, Brenner BM; RENAAL Investigators. Shahinfar S, et al. Among authors: zhang z. Kidney Int Suppl. 2005 Jan;(93):S48-51. doi: 10.1111/j.1523-1755.2005.09311.x. Kidney Int Suppl. 2005. PMID: 15663528 Free article. Review. No abstract available.

8

Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.

Zhang Z, Shahinfar S, Keane WF, Ramjit D, Dickson TZ, Gleim GW, Mogensen CE, de Zeeuw D, Brenner BM, Snapinn SM. Zhang Z, et al. J Am Soc Nephrol. 2005 Jun;16(6):1775-80. doi: 10.1681/ASN.2004080632. Epub 2005 May 4. J Am Soc Nephrol. 2005. PMID: 15872078

9

Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies.

Carr AA, Kowey PR, Devereux RB, Brenner BM, Dahlöf B, Ibsen H, Lindholm LH, Lyle PA, Snapinn SM, Zhang Z, Edelman JM, Shahinfar S. Carr AA, et al. Among authors: zhang z. Am J Cardiol. 2005 Dec 1;96(11):1530-6. doi: 10.1016/j.amjcard.2005.07.061. Epub 2005 Oct 17. Am J Cardiol. 2005. PMID: 16310435 Clinical Trial.

10

Losartan: lessons learned from the RENAAL study.

Shahinfar S, Lyle PA, Zhang Z, Keane WF, Brenner BM. Shahinfar S, et al. Among authors: zhang z. Expert Opin Pharmacother. 2006 Apr;7(5):623-30. doi: 10.1517/14656566.7.5.623. Expert Opin Pharmacother. 2006. PMID: 16553578 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109,851 results

Search Page

Filters